Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-23

FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Cadila Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Cadila Pharmaceuticals' rosuvastatin calcium as an original generic product (ANDA 207453) for lowering cholesterol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

ORIG AP for ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM)